The expression of FOXP3 is believed to be modified or reduced in various diseases, including type 1 diabetes (T1D) and multiple sclerosis (MS) in humans, as well as the Scurfy phenotype (which involves the complete absence of T cell regulatory function) in mice (38–40). The gene discussed is FOXP3; the disease is type 1 diabetes mellitus.